Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Purdue professor develops devices to treat glaucoma, cancer

Abstract:
An electronic device no larger than a grain of rice could be a key factor in treating multiple diseases ranging from glaucoma to cancer.

Purdue professor develops devices to treat glaucoma, cancer

West Lafayette, IN | Posted on February 18th, 2010

Babak Ziaie, a professor of electrical and computer engineering, was torn between engineering and medicine when he was deciding what to do with his life. His solution was to work in the Birck Nanotechnology Center developing small and sophisticated machines that could help provide faster and more effective health care.

Ziaie and his team are currently working on a device that will improve the way radiation therapy is applied. Patients will have a small electronic device implanted in or around the cancerous area receiving the treatment. This device will measure the amount of radiation the target area receives and relay this information to medical personnel.

"This system could greatly reduce the side effects of (radiation therapy) because the doses of radiation could be much more precise," Ziaie said. "We are the only group to be doing this kind of research."

A prototype of the device has been developed and testing is in progress. Another product from Ziaie that has been fabricated is a "plug" for the human eye.

"Sometimes, when a patient has glaucoma, pressure in the eye must be corrected with surgery," Ziaie said. "We have developed a glaucoma device that protects the eye after surgery."

The device fits into an opening in the eye and can act as a drain for excess pressure. If ignored, this pressure could damage the optic nerves that allow a person to see, possibly leading to permanent loss of vision.

The device can drain very small amounts of pressure and is biodegradable. This means that it will completely dissolve in about two weeks without harming the body.

Amani Salim is a graduate student in engineering education and a part of Ziaie's team. Salim said Ziaie encourages his team to expand on their own original concepts.

"Ziaie is dedicated to research. (He is) not a micromanager," Salim wrote in an e-mail. "It is up to (me) to think and see which ideas to pursue."

The team has many other projects and ideas, including the development of methods to deliver drugs to the brain, measure pressure in the brain and bladder, and track tumor progression throughout the body.

Trials on animals are conducted in conjunction with the Indiana University School of Medicine while all of the engineering work and fabrication takes place at Purdue.

"Seventy percent of my research is clinically based," Ziaie said. "My goal is to get products to patients for treatment."

####

For more information, please click here

Copyright © Purdue University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Possible Futures

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Hybrid nanoantennas -- next-generation platform for ultradense data recording April 28th, 2016

Academic/Education

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

The Ottawa Hospital Research Institute uses the ZetaView from Particle Metrix to study membrane microparticles as potential biomarkers for underlying diseases April 12th, 2016

FEI Partners with Five Pharmaceutical Companies, the Medical Research Council and the University of Cambridge to form Cryo-EM Research Consortium April 5th, 2016

SUNY Poly, in Collaboration with the George Washington School of Medicine and Health Sciences and Stony Brook University, Demonstrates Pioneering Method to Visualize and Identify Engineered Nanoparticles in Tissue March 25th, 2016

Molecular Machines

Researchers create artificial protein to control assembly of buckyballs April 27th, 2016

Physicists build engine consisting of one atom: World's smallest heat engine uses just a single particle April 17th, 2016

Revealing the fluctuations of flexible DNA in 3-D: First-of-their-kind images by Berkeley Lab-led research team could aid in use of DNA to build nanoscale devices March 31st, 2016

Physicists prove energy input predicts molecular behavior: Theoretical proof could lead to more reliable nanomachines March 22nd, 2016

Nanomedicine

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Nanobiotechnology

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic